Change search criteria ↓

Search results

144 projects found matching your search criteria:

  1. 101. Genome abberations, p53 status and nitrosative-oxidative stress manifestation during establishment of methotrexate-induc…

    Principal investigator: dr hab. Magdalena Dąbrowska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 1, Panel: NZ4

  2. 102. Effect of dietary modulation of RAGE/AGE axis on prostatic neuroendocrine differentiation and the efficacy of anticancer…

    Principal investigator: dr Wawrzyniec Dobrucki

    Gdański Uniwersytet Medyczny

    Call: OPUS 29, Panel: NZ7

  3. 103. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor…

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 24, Panel: NZ4

  4. 104. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat…

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 29, Panel: NZ7

  5. 105. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m…

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA 20, Panel: NZ6

  6. 106. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

    Principal investigator: dr hab. Angelika Muchowicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 25, Panel: NZ6

  7. 107. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

    Call: POLONEZ BIS 3, Panel: NZ5

  8. 108. Oncogene competition - a new interplay mechanism of mutant p53 with CMYC and mutant KRAS in human cancers.

    Principal investigator: dr hab. Dawid Włodzimierz Walerych

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 23, Panel: NZ5

  9. 109. The use of surface proteins to capture cancer cells with functionalized magnetic nanoparticles as an innovative theranos…

    Principal investigator: dr hab. Joanna Danuta Dulińska-Litewka

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 20, Panel: NZ5

  10. 110. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  11. 111. Tyrosine-modified polyethylenimine polymers as a promising vectors for siRNA delivery in synergistic cancer immunotherap…

    Principal investigator: Małgorzata Kubczak

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 19, Panel: NZ5

  12. 112. Application of small compounds in the epigenetic therapy of malignant brain gliomas

    Principal investigator: prof. Mirosława Zofia Naskręt-Barciszewska

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 19, Panel: NZ5

  13. 113. Ecto-enzymes in interactions of vascular endothelium with blood circulating cells in physiology, pathology and therapy; …

    Principal investigator: dr Barbara Anna Kutryb-Zając

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: SONATA 15, Panel: NZ3

  14. 114. Multimodal gold nanoparticles as potential radiopharmaceuticals in targeted radionuclide therapy

    Principal investigator: dr Agnieszka Majkowska-Pilip

    Instytut Chemii i Techniki Jądrowej

    Call: SONATA 14, Panel: ST4

  15. 115. Gain-of-function complement C2 mutant as a supporter of anti-CD20 therapy in murine lymphoma model

    Principal investigator: Aleksandra Urban

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: PRELUDIUM 15, Panel: NZ6

  16. 116. Synergistic effect of alternating magnetic field and light conversion within Ist and IInd biological optical window on n…

    Principal investigator: dr hab. Robert Pązik

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

    Call: OPUS 13, Panel: ST5

  17. 117. Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein

    Principal investigator: dr Łukasz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

    Call: SONATA 11, Panel: NZ7

  18. 118. Nanoparticle conjugates with the monoclonal antibody - a new opening in target tumor therapy

    Principal investigator: Monika Anna Marcinkowska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 10, Panel: NZ3

  19. 119. Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h…

    Principal investigator: Zofia Felicja Bielecka

    Wojskowy Instytut Medyczny

    Call: PRELUDIUM 9, Panel: NZ5

  20. 120. Photosensitizing properties and photodynamic efficiency of a new functionalized fullerene in liposomes and cancer cells …

    Principal investigator: Anna Magdalena Kozińska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 3, Panel: NZ1

  21. 121. ErbB2-ErbB3/CD151/laminin binding integrins in breast carcinoma: Implications for tumour prognostication and therapy

    Principal investigator: prof. Radzisław Kordek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 1, Panel: NZ4

  22. 122. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co…

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 26, Panel: NZ7

  23. 123. Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo…

    Principal investigator: prof. Ewelina Wioletta Lipiec

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: ST4

  24. 124. Applications of vibrational spectroscopy and femtosecond spectroscopy in oncological diagnostics of human breast.

    Principal investigator: prof. Halina Abramczyk

    Politechnika Łódzka, Wydział Chemiczny

    Call: OPUS 4, Panel: ST4

  25. 125. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 28, Panel: NZ7

  26. 126. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden…

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

    Call: PRELUDIUM 22, Panel: NZ5

  27. 127. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p…

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM BIS 4, Panel: NZ7

  28. 128. On demand generation of singlet oxygen in organic solutions and water

    Principal investigator: dr Aleksander Gorski

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: OPUS 20, Panel: ST4

  29. 129. Delivery of immuno-activators to phagocytic cells in order to obtain an anti-tumor response

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 20, Panel: NZ7

  30. 130. Increasing the precision of chimeric antigen receptor (CAR)-mediated anticancer immunotherapy by using the chemokine-ind…

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

    Call: OPUS 19, Panel: NZ6

  31. 131. Glucose and chitosan-modified PEG-ylated palladium nanoparticles with various size and shape as potential radiosensitize…

    Principal investigator: dr Bartosz Adrian Klębowski

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

    Call: PRELUDIUM 19, Panel: ST5

  32. 132. Novel bispecific G-quadruplex conjugates as potential anticancer agents

    Principal investigator: dr Carolina Sofia Pereira Roxo

    Instytut Chemii Bioorganicznej PAN

    Call: PRELUDIUM 18, Panel: NZ7

  33. 133. Dual-targeted biodegradable polymeric micelles for anticancer drug delivery

    Principal investigator: dr Katarzyna Jelonek

    Centrum Materiałów Polimerowych i Węglowych PAN

    Call: SONATA BIS 9, Panel: NZ7

  34. 134. Epigenetic effect on therapeutic activities of all-trans-retinoic acid in acute myeloid leukemia

    Principal investigator: prof. Arthur Zygmunt Zelent

    Instytut Genetyki i Hodowli Zwierząt PAN

    Call: OPUS 17, Panel: NZ5

  35. 135. Preparation and investigation of multifunctional biomaterials based on nanoapatites for possible application in bone tum…

    Principal investigator: dr Paulina Teresa Sobierajska

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

    Call: PRELUDIUM 14, Panel: ST5

  36. 136. Phosphorus dendrimers as carriers of photosensitizers - in vivo studies

    Principal investigator: prof. Barbara Teresa Klajnert-Maculewicz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 13, Panel: NZ7

  37. 137. Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 12, Panel: NZ6

  38. 138. Chemically modified mRNA for studies on cellular processes and therapeutic applications

    Principal investigator: prof. Jacek Jemielity

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 11, Panel: ST5

  39. 139. Role of the selected anti-tumor agents transported by electropermeabilization to the drug-sensitive and drug-resistant c…

    Principal investigator: dr Joanna Barbara Weżgowiec

    Politechnika Wrocławska, Wydział Podstawowych Problemów Techniki

    Call: PRELUDIUM 8, Panel: NZ7

  40. 140. Studies on the biological activity of selected aminomethylidenebisphosphonic acids

    Principal investigator: dr Anna Nasulewicz-Goldeman

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 7, Panel: NZ4

  41. 141. Cellular and molecular mechanism of action of PPI dendrimer complexes with nucleoside analogue anticancer drugs

    Principal investigator: prof. Barbara Teresa Klajnert-Maculewicz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 7, Panel: NZ3

  42. 142. Studying phosphorus dendrimers as system transporting photosensitizers

    Principal investigator: prof. Barbara Teresa Klajnert-Maculewicz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: HARMONIA 4, Panel: NZ1

  43. 143. Alkylphosphocholines in membrane environment - the study of interactions in two- and three-dimensional

    Principal investigator: dr Anita Natasza Wnętrzak

    Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

    Call: PRELUDIUM 4, Panel: NZ1

  44. 144. Evaluation of peroxiredoxins 1 and 2 along with the thioredoxin-thioredoxin reductase system as new therapeutic targets …

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

    Call: OPUS 4, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski